12/5
07:03 pm
rxrx
Recursion Pharmaceuticals (RXRX) Up 6.5% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals (RXRX) Up 6.5% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
12/4
07:55 pm
rxrx
Lightning Round: Recursion Pharmaceuticals and NuScale Power [CNBC]
Medium
Report
Lightning Round: Recursion Pharmaceuticals and NuScale Power [CNBC]
12/4
06:58 pm
rxrx
Cramer's Lightning Round: Recursion Pharmaceuticals ‘has been horrendous' [CNBC]
Medium
Report
Cramer's Lightning Round: Recursion Pharmaceuticals ‘has been horrendous' [CNBC]
12/1
08:30 am
rxrx
Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025
Medium
Report
Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025
11/19
07:04 pm
rxrx
Is Recursion Pharmaceuticals a Meme Stock? [Yahoo! Finance]
Medium
Report
Is Recursion Pharmaceuticals a Meme Stock? [Yahoo! Finance]
11/18
10:17 am
rxrx
Recursion Pharmaceuticals: What To Make Of This AI-Based Drug Discovery Leader? [Seeking Alpha]
Medium
Report
Recursion Pharmaceuticals: What To Make Of This AI-Based Drug Discovery Leader? [Seeking Alpha]
11/18
08:45 am
rxrx
Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
Low
Report
Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
11/13
09:42 am
rxrx
Tempus: Diagnostics Substance, AI Flash [Seeking Alpha]
Medium
Report
Tempus: Diagnostics Substance, AI Flash [Seeking Alpha]
11/12
10:51 am
rxrx
Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock [Yahoo! Finance]
Low
Report
Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock [Yahoo! Finance]
11/5
06:30 am
rxrx
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
Low
Report
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
11/5
06:28 am
rxrx
Recursion Announces CEO Transition Plan to Drive Next Phase of Growth
Medium
Report
Recursion Announces CEO Transition Plan to Drive Next Phase of Growth
11/4
08:00 am
rxrx
Recursion to Participate in Upcoming Investor Conferences
Medium
Report
Recursion to Participate in Upcoming Investor Conferences
10/28
08:00 am
rxrx
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
Medium
Report
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
10/21
11:08 am
rxrx
Up 25% in 1 Month, Is This Stock a Buy? [Yahoo! Finance]
Low
Report
Up 25% in 1 Month, Is This Stock a Buy? [Yahoo! Finance]
10/12
06:34 am
rxrx
Recursion Pharmaceuticals (RXRX): Assessing Valuation with AI Strategy in Focus Ahead of Key CEO Presentation [Yahoo! Finance]
Medium
Report
Recursion Pharmaceuticals (RXRX): Assessing Valuation with AI Strategy in Focus Ahead of Key CEO Presentation [Yahoo! Finance]
10/9
05:29 am
rxrx
Recursion Pharmaceuticals (RXRX) Climbs 16% Ahead of AI Conference [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals (RXRX) Climbs 16% Ahead of AI Conference [Yahoo! Finance]
10/8
11:36 am
rxrx
Recursion Pharmaceuticals, Inc. (RXRX): A Bull Case Theory [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals, Inc. (RXRX): A Bull Case Theory [Yahoo! Finance]
10/3
08:10 pm
rxrx
Recursion Pharmaceuticals (RXRX) Surges 8.2%: Is This an Indication of Further Gains? [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals (RXRX) Surges 8.2%: Is This an Indication of Further Gains? [Yahoo! Finance]
10/3
09:40 am
rxrx
Evaluating Recursion After a 19% Rally Amid Renewed Interest in Biotech AI Initiatives [Yahoo! Finance]
Low
Report
Evaluating Recursion After a 19% Rally Amid Renewed Interest in Biotech AI Initiatives [Yahoo! Finance]
9/30
03:08 pm
rxrx
Needham Reiterates a Buy on Recursion Pharmaceuticals (RXRX) [Yahoo! Finance]
Low
Report
Needham Reiterates a Buy on Recursion Pharmaceuticals (RXRX) [Yahoo! Finance]
9/29
01:37 am
rxrx
Jim Cramer on Recursion: “I Need to See a Proof of Concept Here” [Yahoo! Finance]
Medium
Report
Jim Cramer on Recursion: “I Need to See a Proof of Concept Here” [Yahoo! Finance]
9/28
10:37 am
rxrx
Where Will Recursion Pharmaceuticals Be in 5 Years? [Yahoo! Finance]
Medium
Report
Where Will Recursion Pharmaceuticals Be in 5 Years? [Yahoo! Finance]
9/28
10:10 am
rxrx
The Biotech Stock That's Too Risky for Most Investors [Yahoo! Finance]
Medium
Report
The Biotech Stock That's Too Risky for Most Investors [Yahoo! Finance]
9/26
05:33 am
rxrx
Prediction: 2 Stocks That Will Be Worth More Than BigBear.ai 5 Years From Now [Yahoo! Finance]
Low
Report
Prediction: 2 Stocks That Will Be Worth More Than BigBear.ai 5 Years From Now [Yahoo! Finance]
9/21
09:50 am
rxrx
Recursion Pharmaceuticals, Inc. (RXRX) Secures $12.5M Milestone From Rallybio as REV102 Advances [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals, Inc. (RXRX) Secures $12.5M Milestone From Rallybio as REV102 Advances [Yahoo! Finance]